PLYMOUTH, Minn.--(BUSINESS WIRE)--Monteris® Medical Inc. (Monteris) announced today it has closed a $7.8 million financing round to support continued commercialization of the NeuroBlate System® in the North American neurosurgery market. Business Development Bank of Canada (BDC) led the round. Other investors included the SWMF Life Science Fund, and several independent parties. The total capital raised in 2012 approached $16 Million.
"I consider the support shown by our investors to be a vote of confidence and evidence that we met milestones set during our previous financing," says John Schellhorn, President and CEO of Monteris. "We are proud of our team. They are working extremely hard to deliver a new version of the NeuroBlate System® to our customers. The objectives of the new version, which is currently being reviewed by FDA, are to reduce treatment times, provide better planning tools, be easier to use and serve as a platform for ongoing development.” “The monies raised in this round will be used to accelerate the company’s commercialization of the third generation NeuroBlate System,” added Monteris Chairman Kevin McGarry. “Our customer pipeline continues to grow as physicians confirm the NeuroBlate System is able to provide new options for brain tumor patients.”
"Monteris Medical remains an exciting opportunity for BDC." states Gary Bantle, Partner, BDC Health Venture Fund. "Monteris has all of the key ingredients in place to be successful: a technology that works, a strong management team, regulatory clearance of key products and reimbursement for hospitals. We are pleased to support the company’s ongoing commercialization efforts."
About Monteris Medical
Formed in 1999, Monteris Medical is a
privately held medical device company dedicated to the development of
innovative MRI-guided, laser-based brain cancer treatments. Monteris
Medical markets the NeuroBlate System®, a neurosurgical ablation device
providing controlled therapy for difficult-to-treat brain tumors.
Monteris also offers the AXiiiS® Stereotactic Miniframe; a single use
platform for image-guided, stereotactic brain biopsy; and the AtamA™
Head Coil and Stabilization System for MRI-guided neurosurgical
procedures requiring head fixation.
www.monteris.com
About BDC
Canada’s Business Development Bank, BDC puts
entrepreneurs first. With almost 1,900 employees and more than 100
business centres across the country, BDC offers financing, venture
capital and consulting services to 29,000 small and medium sized
companies; Their success is vital to Canada’s economic prosperity.
www.bdc.ca